P16 immunostaining patterns in microglandular hyperplasia of the cervix and their significance

International Journal of Gynecological Pathology

Volumn 28, Issue 2, 2009, Pages 107-113

  Roh, Michael H ^a   Agoston, Elin ^a   Birch, Chandler ^a   Crum, Christopher P ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Cervix; HPV; Microglandular hyperplasia; P16

Indexed keywords

CYCLIN E; KI 67 ANTIGEN; PROTEIN P16;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MICROGLANDULAR HYPERPLASIA; PAPILLOMA VIRUS; PRIORITY JOURNAL; SCORING SYSTEM; SQUAMOUS EPITHELIUM; UTERINE CERVIX; VIRUS DETECTION; WART VIRUS;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DISEASES;

EID: 68949198132     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181877a73     Document Type: Article

References (31)

1. Greeley C, Schroeder S, Silverberg SG. Microglandular hyperplasia of the cervix: a true 'pill' lesion? Int J Gynecol Pathol 1995;14:50-54
2. Wilkinson E, Dufour DR. Pathogenesis of microglandular hyperplasia of the cervix uteri. Obstet Gynecol 1976; 47:189-195
3. Witkiewicz AK, Hecht JL, Cviko A, et al. Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells. Hum Pathol 2005;36:154-161 (Pubitemid 40313573)
4. Park JJ, Sun D, Quade BJ, et al. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol 2000;24:1414-1419
5. Quade BJ, Yang A, Wang Y, et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol. 2001;80:30-36 (Pubitemid 32062084)
6. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-891 (Pubitemid 32594981)
7. Agoff SN, Lin P, Morihara J, et al. P16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003;16:665-673
8. Quade BJ, Park JJ, Crum CP, et al. In vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998;11:1238-1246
9. Qiao X, Bhuiya TA, Spitzer M. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis 2005;9:100-107 (Pubitemid 40464079)
10. Ma L, Fisk JM, Zhang RR, et al. Eosinophilic dysplasia of the cervix: a newly recognized variant of cervical squamous intraepithelial neoplasia. Am J Surg Pathol 2004;28:1474-1484 (Pubitemid 39425514)
11. Wise-Draper TM,Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008;13:1003-1017
12. Chumas JC, Nelson B, Mann WJ, et al. Microglandular hyperplasia of the uterine cervix. Obstet Gynecol 1985;66:406-409
13. Young RH, Scully RE. Uterine carcinomas simulating microglandular hyperplasia: a report of six cases. Am J Surg Pathol 1992;16:1092-1097
14. Yildiz IZ, Usubutun A, Firat P, et al. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Pathol Res Pract 2007;203:445-449 (Pubitemid 46860176)
15. Kong CS, Balzer BL, Troxell ML, et al. P16INK4a immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007;31:33-43.
16. Liang J, Mittal KR, Wei JJ, et al. Utility of p16INK4a, CEA, Ki67, P53, and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol 2007;26:71-75 (Pubitemid 46036962)
17. Regauer S, Reich O. CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CINIII). Histopathology 2007;50:629-635
18. Riethdorf L, Riethdorf S, Lee KR, et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol 2002;33:899-904.
19. Horree N, Heintz AP, Sie-Go DM, et al. P16 is consistently expressed in endometrial tubal metaplasia. Cell Oncol 2007;29:37-45. (Pubitemid 46535189)
20. Cameron RI, Maxwell P, Jenkins D, et al. Immunohistochemical staining with MIB1, bcl2, and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tuboendometrial metaplasia, endometriosis, and microglandular hyperplasia. Histopathology 2002;41:313-321. (Pubitemid 35279028)
21. McCluggage WG, Ganesan R, Hirschowitz L, et al. Ectopic prostatic tissue in the uterine cervix and vagina: report of a series with a detailed immunohistochemical analysis. Am J Surg Pathol 2006;30:209-215 (Pubitemid 43740190)
22. Hashi A, Xu JY, Kondo T, et al. p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2006;25:187-194 (Pubitemid 44620184)
23. Natarajan E, Omobono JD II, Jones JC, et al. Co-expression of p16INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression. J Investig Dermatol Symp Proc 2005;10:72-85.
24. TM) as a marker of cervical dysplasia and neoplasia. Diagn Cytopathol 2002;27:365-370
25. INK4a as an adjunct test in liquid-based cytology. Anal Quant Cytol Histol 2003;25:8-11.
26. INK4a and HPV-PCR on ThinPrep samples with histological follow-up. Diagn Cytopathol 2008;36:453-459
27. Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytological correlations. Am J Surg Pathol 2003;27:187-193. (Pubitemid 36152227)
28. Samama B, Schaeffer C, Boehm N. P16 expression in relation to human papillomavirus in liquid-based cervical smears. Gynecol Oncol 2008;109:285-290
29. Nassar A, O'Reilly K, Cohen C, et al. Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations. Diagn Cytopathol 2008;36:142-148 (Pubitemid 351312127)
30. Duncan L, Jacob S, Hubbard E. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance. Cancer 2008;114:34-48. (Pubitemid 351304611)
31. Selvaggi SM, Haefner HK. Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears. Diagn Cytopathol 1997;16:168-173.